23andMe Holding Co.
ME,
said Tuesday it’s launching a health action plan that will offer its clients personalized recommendations based on genetic and other health data. The South San Francisco-based provider of home DNA kits said the plan will offer suggestions on modifying behavior related to sleep, diet and exercise, as well as on potential new treatments or activities for certain health conditions. It will also dig into health data, such as diagnoses or family history, to further personalize recommendations. “Eligible customers may also receive recommendations for further clinical action, like getting a blood test, which can now be coordinated directly through 23andMe,” the company said in a statement. The stock was up 2% premarket but has fallen 64% in the year to date, while the S&P 500
SPX,
has gained 8.5%.
Read the full article here
